Page last updated: 2024-10-30

mecamylamine and Hypoglycemia

mecamylamine has been researched along with Hypoglycemia in 2 studies

Mecamylamine: A nicotinic antagonist that is well absorbed from the gastrointestinal tract and crosses the blood-brain barrier. Mecamylamine has been used as a ganglionic blocker in treating hypertension, but, like most ganglionic blockers, is more often used now as a research tool.

Hypoglycemia: A syndrome of abnormally low BLOOD GLUCOSE level. Clinical hypoglycemia has diverse etiologies. Severe hypoglycemia eventually lead to glucose deprivation of the CENTRAL NERVOUS SYSTEM resulting in HUNGER; SWEATING; PARESTHESIA; impaired mental function; SEIZURES; COMA; and even DEATH.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Reno, CM1
Bayles, J1
Huang, Y1
Oxspring, M1
Hirahara, AM1
Dosdall, DJ1
Fisher, SJ1
HUEGIN, W1

Reviews

1 review available for mecamylamine and Hypoglycemia

ArticleYear
[PROBLEMS OF ANESTHESIA IN PATIENTS UNDER TREATMENT OF HYPERTENSION].
    Der Anaesthesist, 1963, Volume: 12

    Topics: Anesthesia; Antihypertensive Agents; Bretylium Compounds; Cardiovascular Diseases; Chlorothiazide; C

1963

Other Studies

1 other study available for mecamylamine and Hypoglycemia

ArticleYear
Severe Hypoglycemia-Induced Fatal Cardiac Arrhythmias Are Mediated by the Parasympathetic Nervous System in Rats.
    Diabetes, 2019, Volume: 68, Issue:11

    Topics: Animals; Arrhythmias, Cardiac; Benzodiazepinones; Disease Models, Animal; Hypoglycemia; Male; Mecamy

2019